JAMA Neurology Author Interviews

Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

06.22.2020 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Interview with Suzanne Craft, PhD, author of Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial

More episodes from JAMA Neurology Author Interviews